SWAV

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About ShockWave Medical Inc

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.
CEO
Douglas Godshall
Employees
2019
Headquarters

5403 Betsy Ross Dr
Santa Clara, California 95054
Phone: 15102794262
shockwavemedical.com

News

Shockwave Medical’s Structural Shift Following Major Merger
May 31, 2024 21:17pm

An update from Shockwave Medical (SWAV) is now available. The recent merger of a company has triggered significant changes for note holders and sto…


Source:TipRanks
Sarepta Therapeutics to replace Shockwave Medical in the S&P MidCap 400
May 29, 2024 22:02pm

Sarepta Therapeutics is set to replace Shockwave Medical in the S&P MidCap 400 index, effective June 3, according to S&P Dow Jones Indices.


Source:Seeking Alpha
Trinh Phung At Shockwave Medical Capitalizes: Options Exercised, Resulting In $6.48M
May 22, 2024 15:02pm

A substantial insider activity was disclosed on May 21, as Phung, VP at Shockwave Medical (NASDAQ: SWAV ), reported the exercise of a large sell of company stock options. What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Phung, VP at Shockwave Medical, exercising stock options for 19,763 shares of SWAV. The total transaction was valued at $6,482,222. Currently, Shockwave Medical shares are trading up 1.37%, priced at $334.16 during Wednesday''s morning. This values Phung''s 19,763 shares at $6,482,222. About Shockwave Medical Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease ("atherosclerosis") through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy ("IVL").


Source:Benzinga
Shockwave Medical gains after HSR waiting period for sale to J&J expires
May 21, 2024 20:46pm

No summary available.


Source:Seeking Alpha